FOLD Other Income/Expenses (Net)

Amicus Therapeutics Inc · Other Income/Expenses (Net)

FOLD logo

FOLD Other Income/Expenses (Net)

Latest reported-$32.60M
FOLD TTM Other Income/Expenses (Net) ($0.00 → -$32.60M)
High-resolution chart · PNG

FOLD other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amicus Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-32,598,000
-27,832,000
-42,711,000
-47,863,000
-53,632,000
-73,563,000
-66,371,000
-73,169,000
-72,890,000
-72,673,000
-60,414,000
-39,390,000
-29,919,000
-10,318,000
-22,972,000
-30,205,000
-35,120,000
-35,729,000
-38,175,000
-27,753,000
-27,256,000
-19,359,000
-13,591,000
-23,551,000
-51,873,000
-59,199,000
-57,477,000
-64,636,000
-20,910,000
-19,094,000
-17,178,000
-3,641,000
-11,436,000
-12,369,000
-13,219,000
-15,154,000
-12,923,000
-8,120,000
-5,908,000
-3,137,000
-2,677,000
-1,021,000
-1,599,000
-1,757,000
-1,849,000
-3,450,000
-2,571,000
-1,567,000
-1,452,000
3,658,000
3,738,000
3,086,000
901,000
-1,023,000
1,726,000
3,805,000
2,846,000
2,416,000
-3,051,000
-3,763,000
-238,000
-533,000
1,604,000
461,000
784,000
1,497,000
2,422,000
3,466,000
4,601,000
5,584,000
6,117,000
5,423,000
4,328,000
2,618,000
1,115,000
537,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.